A project in Barking and Dagenham has been nominated for an award. The work of the Physical Health Care for patients with Psychosis (PHCP) project has been shortlisted in the Health Initiative of the Year for this year’s Chemist and Druggist Awards.
The C+D Awards will be the 11th time the ceremony has been staged and will take place at the Intercontinental hotel on Park Lane, London on Wednesday 4 July.
A 28-strong independent panel of judges whittled down 156 entries into a list of 97 finalists across 13 categories.
The Physical Health Care for patients with Psychosis (PHCP) project was run in collaboration with North East London Local Pharmaceutical Committee (NELLPC) and local pharmacies – a unique collaborative approach between secondary care, community pharmacy and primary care. The year-long project started in October 2016 and aimed to carry out physical health checks for patients with psychosis in the community by pharmacists.
Robert Neale, Transformation Project Manager said: “We are delighted that the project has received this award nomination. It’s deserved recognition for a project that did a lot to help and improve the health and wellbeing of patients in Barking and Dagenham.
“The project saw NELFT working in successful collaboration with NELLPC and local pharmacies in the borough to provide a unique and comprehensive service. By utilising local pharmacies for the physical health checks we could offer service users healthcare close to their home when collecting their medication. It allowed individuals to be empowered to take greater control of their own wellbeing and receive up-to-date lifestyle advice. The project resulted in a significantly increased uptake of physical health checks for this patient cohort, which we hope to continue and replicate elsewhere.”
The project features in a video, which explains more about the joint collaboration.
The main results of the project were:
- 140 of patients had a physical health check within the community pharmacy which equates to 77% of all patients who were offered health checks in community pharmacies (140/180). (This compares very favourably with national data and previous NELFT data – NELFT is 36% of patients have all health checks compared to the project which was 70%. NHS results: 42% community and 59% inpatient. So our community project with pharmacists was able to complete more health checks than inpatients setting.
- 71% of attendees at community pharmacies had all five Lester cardiometabolic risk factors monitored which is significantly better than NELFT standard care in B&D (treatment as usual TAU) where 36% of patients had all 5 checks.